Decades of research push cytomegalovirus vaccine closer to reality

Researchers review decades of progress in human cytomegalovirus (HCMV) vaccine development, emphasizing challenges, innovative platforms, and the critical need for effective prevention strategies.

Longer treatment gave better liver outcomes for MASH patients, Akero drug study shows

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted

March 4, 2024

Intermountain Primary Children’s Hospital Launches $9M Genomic Initiative for Kids

What You Should Know: – Intermountain Primary Children’s Hospital, in partnership with the University of Utah Health Department of Pediatrics, has announced a groundbreaking initiative

July 29, 2024

New framework established for defining prebiotics

The concept of prebiotics – defined as substrates that are selectively utilized by host microorganisms conferring a health benefit – was introduced in the scientific

October 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.